1. Home
  2. AERT vs PMN Comparison

AERT vs PMN Comparison

Compare AERT & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aeries Technology Inc.

AERT

Aeries Technology Inc.

HOLD

Current Price

$0.53

Market Cap

27.9M

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$8.11

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AERT
PMN
Founded
2012
2004
Country
Singapore
Canada
Employees
N/A
N/A
Industry
Professional Services
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
23.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AERT
PMN
Price
$0.53
$8.11
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$72.67
AVG Volume (30 Days)
61.0K
17.4K
Earning Date
02-13-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$69,346,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$6.27
52 Week High
$1.52
$39.75

Technical Indicators

Market Signals
Indicator
AERT
PMN
Relative Strength Index (RSI) 45.22 62.02
Support Level $0.51 $7.98
Resistance Level $0.54 $8.51
Average True Range (ATR) 0.02 0.48
MACD 0.00 -0.15
Stochastic Oscillator 42.41 73.29

Price Performance

Historical Comparison
AERT
PMN

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: